Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations-Reference-Cited by-同舟云学术

Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations

Published:2019-03-28 Issue: Volume: Page:
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Grimm Julia¹,Zeuschner Philip¹,Janssen Martin¹,Wagenpfeil Stefan²,Hartmann Arndt³,Stöhr Christine³,Keck Bastian⁴,Kahlmeyer Andreas⁴,Stöckle Michael¹,Junker Kerstin¹^ORCID

Affiliation:

1. Department of Urology and Pediatric UrologySaarland University Homburg Germany

2. Institute of Medical Biometry, Epidemiology and Medical InformaticsSaarland University Homburg Germany

3. Institute of Pathology, University Hospital Erlangen, Friedrich‐Alexander‐University Erlangen‐Nuremberg Erlangen Germany

4. Department of UrologyUniversity Hospital Erlangen, Friedrich‐Alexander‐University Erlangen‐Nuremberg Erlangen Germany

Funder

Stiftung Deutsche Krebshilfe

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22749

Reference32 articles.

1. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study

2. Renal cell cancer stage migration

3. Identification of Genomic Alterations Associated With Metastasis and Cancer Specific Survival in Clear Cell Renal Cell Carcinoma

4. Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH

5. Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma;World Journal of Urology;2023-06-29

2. Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma;BJU International;2023-03-07

3. All is not lost: learning from 9p21 loss in cancer;Trends in Immunology;2022-05

4. Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations;World Journal of Urology;2022-03-16

5. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy;Investigative and Clinical Urology;2022